259 related articles for article (PubMed ID: 8903477)
1. Induction of apoptosis by ribosome-inactivating proteins and related immunotoxins.
Bolognesi A; Tazzari PL; Olivieri F; Polito L; Falini B; Stirpe F
Int J Cancer; 1996 Nov; 68(3):349-55. PubMed ID: 8903477
[TBL] [Abstract][Full Text] [Related]
2. Anti-CD30 (BER=H2) immunotoxins containing the type-1 ribosome-inactivating proteins momordin and PAP-S (pokeweed antiviral protein from seeds) display powerful antitumour activity against CD30+ tumour cells in vitro and in SCID mice.
Terenzi A; Bolognesi A; Pasqualucci L; Flenghi L; Pileri S; Stein H; Kadin M; Bigerna B; Polito L; Tazzari PL; Martelli MF; Stirpe F; Falini B
Br J Haematol; 1996 Mar; 92(4):872-9. PubMed ID: 8616080
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of immunotoxins containing single-chain ribosome-inactivating proteins and an anti-CD22 monoclonal antibody (OM124): in vitro and in vivo studies.
Bolognesi A; Tazzari PL; Olivieri F; Polito L; Lemoli R; Terenzi A; Pasqualucci L; Falini B; Stirpe F
Br J Haematol; 1998 Apr; 101(1):179-88. PubMed ID: 9576199
[TBL] [Abstract][Full Text] [Related]
4. Toxicity of ribosome-inactivating proteins-containing immunotoxins to a human bladder carcinoma cell line.
Battelli MG; Polito L; Bolognesi A; Lafleur L; Fradet Y; Stirpe F
Int J Cancer; 1996 Feb; 65(4):485-90. PubMed ID: 8621232
[TBL] [Abstract][Full Text] [Related]
5. Targeting of type 1 ribosome-inactivating proteins to CD30+ or CD25+ hematologic neoplasias by bispecific antibodies.
Sforzini S; Bolognesi A; Meazza R; Marciano S; Tazzari PL; Stein H; Stirpe F; Ferrini S
J Hematother; 1995 Oct; 4(5):429-32. PubMed ID: 8581380
[TBL] [Abstract][Full Text] [Related]
6. High sensitivity of cultured human trophoblasts to ribosome-inactivating proteins.
Battelli MG; Montacuti V; Stirpe F
Exp Cell Res; 1992 Jul; 201(1):109-12. PubMed ID: 1612115
[TBL] [Abstract][Full Text] [Related]
7. Targeting of saporin to Hodgkin's lymphoma cells by anti-CD30 and anti-CD25 bispecific antibodies.
Sforzini S; de Totero D; Gaggero A; Ippoliti R; Glennie MJ; Canevari S; Stein H; Ferrini S
Br J Haematol; 1998 Sep; 102(4):1061-8. PubMed ID: 9734659
[TBL] [Abstract][Full Text] [Related]
8. A comparison of anti-lymphocyte immunotoxins containing different ribosome-inactivating proteins and antibodies.
Bolognesi A; Tazzari PL; Tassi C; Gromo G; Gobbi M; Stirpe F
Clin Exp Immunol; 1992 Sep; 89(3):341-6. PubMed ID: 1516253
[TBL] [Abstract][Full Text] [Related]
9. Targeting of saporin to CD25-positive normal and neoplastic lymphocytes by an anti-saporin/anti-CD25 bispecific monoclonal antibody: in vitro evaluation.
Tazzari PL; Zhang S; Chen Q; Sforzini S; Bolognesi A; Stirpe F; Xie H; Moretta A; Ferrini S
Br J Cancer; 1993 Jun; 67(6):1248-53. PubMed ID: 8512810
[TBL] [Abstract][Full Text] [Related]
10. In vitro anti-tumour activity of anti-CD80 and anti-CD86 immunotoxins containing type 1 ribosome-inactivating proteins.
Bolognesi A; Polito L; Tazzari PL; Lemoli RM; Lubelli C; Fogli M; Boon L; de Boer M; Stirpe F
Br J Haematol; 2000 Aug; 110(2):351-61. PubMed ID: 10971392
[TBL] [Abstract][Full Text] [Related]
11. An Epstein-Barr virus-infected lymphoblastoid cell line (D430B) that grows in SCID-mice with the morphologic features of a CD30+ anaplastic large cell lymphoma, and is sensitive to anti-CD30 immunotoxins.
Tazzari PL; de Totero D; Bolognesi A; Testoni N; Pileri S; Roncella S; Reato G; Stein H; Gobbi M; Stirpe F
Haematologica; 1999 Nov; 84(11):988-95. PubMed ID: 10553158
[TBL] [Abstract][Full Text] [Related]
12. Purification of immunotoxins containing the ribosome-inactivating proteins gelonin and momordin using high performance liquid immunoaffinity chromatography compared with blue sepharose CL-6B affinity chromatography.
Cumber AJ; Henry RV; Parnell GD; Wawrzynczak EJ
J Immunol Methods; 1990 Dec; 135(1-2):15-24. PubMed ID: 2273254
[TBL] [Abstract][Full Text] [Related]
13. Selective cytotoxic activity of immunotoxins composed of a monoclonal anti-Thy 1.1 antibody and the ribosome-inactivating proteins bryodin and momordin.
Stirpe F; Wawrzynczak EJ; Brown AN; Knyba RE; Watson GJ; Barbieri L; Thorpe PE
Br J Cancer; 1988 Nov; 58(5):558-61. PubMed ID: 3265330
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of growth of breast cancer cells in vitro by the ribosome-inactivating protein saporin 6.
Gasperi-Campani A; Zoli W; Volpi A; Roncuzzi L; Amadori D
Anticancer Res; 1991; 11(2):1007-11. PubMed ID: 2064307
[TBL] [Abstract][Full Text] [Related]
15. Immunotoxins containing saporin linked to different CD2 monoclonal antibodies: in vitro evaluation.
Tazzari PL; Bolognesi A; De Totero D; Lemoli RM; Fortuna A; Conte R; Crumpton MJ; Stirpe F
Br J Haematol; 1994 Jan; 86(1):97-105. PubMed ID: 7912101
[TBL] [Abstract][Full Text] [Related]
16. Polynucleotide: adenosine glycosidase activity of immunotoxins containing ribosome-inactivating proteins.
Barbieri L; Bolognesi A; Valbonesi P; Polito L; Olivieri F; Stirpe F
J Drug Target; 2000; 8(5):281-8. PubMed ID: 11328656
[TBL] [Abstract][Full Text] [Related]
17. Some ribosome-inactivating proteins depurinate ribosomal RNA at multiple sites.
Barbieri L; Ferreras JM; Barraco A; Ricci P; Stirpe F
Biochem J; 1992 Aug; 286 ( Pt 1)(Pt 1):1-4. PubMed ID: 1520257
[TBL] [Abstract][Full Text] [Related]
18. Selective killing of CD4+ and CD8+ cells with immunotoxins containing saporin.
Barbieri L; Bolognesi A; Dinota A; Lappi DA; Soria M; Tazzari PL; Stirpe F
Scand J Immunol; 1989 Sep; 30(3):369-72. PubMed ID: 2571186
[TBL] [Abstract][Full Text] [Related]
19. Monoclonal anti-human T cell antibody and PAP-s conjugate--preparation and selective cytotoxic properties on leukemic cell.
Chu JY; Yang AD; Wang BM; Hu Z; Zhu XM; Zhang HJ; Qu JH; Luo LY; Guo R; Shi LR
J Tongji Med Univ; 1990; 10(1):15-8. PubMed ID: 2348483
[TBL] [Abstract][Full Text] [Related]
20. An immunotoxin composed of monoclonal anti-Thy 1.1 antibody and a ribosome-inactivating protein from Saponaria officinalis: potent antitumor effects in vitro and in vivo.
Thorpe PE; Brown AN; Bremner JA; Foxwell BM; Stirpe F
J Natl Cancer Inst; 1985 Jul; 75(1):151-9. PubMed ID: 3859688
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
